妊娠期糖尿病患者血清Pannexin-1表达与胰岛素抵抗相关性分析
Correlation Analysis of Serum Pannexin-1 Expression and Insulin Resistance in Patients with Gestational Diabetes Mellitus
DOI: 10.12677/acm.2025.1541176, PDF,   
作者: 李 康:青岛大学青岛医学院,山东 青岛;临淄区妇幼保健院(齐都医院)产科,山东 淄博;左建新*:青岛大学附属医院产科,山东 青岛
关键词: 妊娠期糖尿病胰岛素抵抗Pannexin-1Gestational Diabetes Mellitus (GDM) Insulin Resistance Pannexin-1
摘要: 目的:探讨妊娠期糖尿病(GDM)患者外周血中Pannexin-1 (PANX1)表达与胰岛素抵抗的相关性分析。方法:选取2023年12月至2024年11月在青岛大学附属医院产科住院分娩的30例GDM患者作为实验组,同时选取30例正常妊娠孕妇作为对照组。收集两组孕妇的外周血,采用酶联免疫吸附试验(ELISA)检测外周血中PANX1的浓度。使用稳态模型评估胰岛素抵抗指数(HOMA-IR)及胰岛素抵抗情况,并进行相关性分析。结果:GDM组与对照组在年龄、孕周、孕前BMI等一般资料无显著差异(P > 0.05),空腹血糖(FBG)、空腹胰岛素(FINS)和HOMA-IR,GDM组显著高于对照组(P < 0.05)。GDM患者外周血中PANX1的浓度显著高于对照组(184.4 ± 106.03 pg/mL vs. 87.34 ± 2.68 pg/mL, P < 0.001)。PANX1水平与HOMA-IR呈正相关(P < 0.05)。结论:GDM患者外周血中PANX1水平的升高与胰岛素抵抗的增加有关,PANX1可能在GDM的发病机制中发挥重要作用。
Abstract: Objective: To investigate the correlation between the expression of Pannexin-1 (PANX1) in the peripheral blood of patients with gestational diabetes mellitus (GDM) and insulin resistance. Methods: This study included 30 pregnant women diagnosed with GDM who delivered at the Affiliated Hospital of Qingdao University from December 2023 to November 2024 as the experimental group, and 30 healthy pregnant women as controls. Peripheral blood samples were collected from both groups. The concentration of PANX1 in peripheral blood was measured using enzyme-linked immunosorbent assay (ELISA). Insulin resistance was assessed using the homeostasis model assessment of insulin resistance (HOMA-IR), and correlation analysis was performed. Results: There were no significant differences between the GDM and control groups in terms of age, gestational age, or pre-pregnancy BMI (P > 0.05). However, the GDM group had significantly higher levels of fasting blood glucose (FBG), fasting insulin (FINS), and HOMA-IR compared to the control group (P < 0.05). The concentration of PANX1 in the peripheral blood of GDM patients was significantly higher than that of the controls (184.4 ± 106.03 pg/mL vs. 87.34 ± 2.68 pg/mL, P < 0.001). PANX1 levels were positively correlated with HOMA-IR (P < 0.05). Conclusion: The elevated levels of PANX1 in the peripheral blood of GDM patients are associated with increased insulin resistance, suggesting that PANX1 may play an important role in the pathogenesis of GDM.
文章引用:李康, 左建新. 妊娠期糖尿病患者血清Pannexin-1表达与胰岛素抵抗相关性分析[J]. 临床医学进展, 2025, 15(4): 2255-2261. https://doi.org/10.12677/acm.2025.1541176

参考文献

[1] Sweeting, A., Wong, J., Murphy, H.R. and Ross, G.P. (2022) A Clinical Update on Gestational Diabetes Mellitus. Endocrine Reviews, 43, 763-793. [Google Scholar] [CrossRef] [PubMed]
[2] Szmuilowicz, E.D., Josefson, J.L. and Metzger, B.E. (2019) Gestational Diabetes Mellitus. Endocrinology and Metabolism Clinics of North America, 48, 479-493. [Google Scholar] [CrossRef] [PubMed]
[3] Juan, J. and Yang, H. (2020) Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China. International Journal of Environmental Research and Public Health, 17, Article 9517. [Google Scholar] [CrossRef] [PubMed]
[4] Ye, W., Luo, C., Huang, J., Li, C., Liu, Z. and Liu, F. (2022) Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis. BMJ, 377, e067946. [Google Scholar] [CrossRef] [PubMed]
[5] Zhao, Y. and Yue, R. (2023) Aging Adipose Tissue, Insulin Resistance, and Type 2 Diabetes. Biogerontology, 25, 53-69. [Google Scholar] [CrossRef] [PubMed]
[6] Hivert, M., White, F., Allard, C., James, K., Majid, S., Aguet, F., et al. (2024) Placental IGFBP1 Levels during Early Pregnancy and the Risk of Insulin Resistance and Gestational Diabetes. Nature Medicine, 30, 1689-1695. [Google Scholar] [CrossRef] [PubMed]
[7] Hivert, M., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., et al. (2024) Pathophysiology from Preconception, during Pregnancy, and Beyond. The Lancet, 404, 158-174. [Google Scholar] [CrossRef] [PubMed]
[8] Zhao, X., Zhang, W., Jiang, F., Chen, X., Chen, C., Wang, M., et al. (2024) Excessive Palmitic Acid Disturbs Macrophage α-Ketoglutarate/Succinate Metabolism and Causes Adipose Tissue Insulin Resistance Associated with Gestational Diabetes Mellitus. Free Radical Biology and Medicine, 222, 424-436. [Google Scholar] [CrossRef] [PubMed]
[9] Luo, Y., Qin, Y., Kong, L., Long, J., Lukacs-Kornek, V., Li, J., et al. (2024) Clinical and Pathological Characteristics of Gestational Diabetes Mellitus with Different Insulin Resistance. Journal of Diabetes and its Complications, 38, Article ID: 108796. [Google Scholar] [CrossRef] [PubMed]
[10] Pavelec, C.M., Young, A.P., Luviano, H.L., Orrell, E.E., Szagdaj, A., Poudel, N., et al. (2024) Cardiomyocyte PANX1 Controls Glycolysis and Neutrophil Recruitment in Hypertrophy. Circulation Research, 135, 503-517. [Google Scholar] [CrossRef] [PubMed]
[11] Hu, C., Hou, T., Xiang, R., Li, X., Li, J., Wang, T., et al. (2024) PANX1-Mediated ATP Release Confers FAM3A’s Suppression Effects on Hepatic Gluconeogenesis and Lipogenesis. Military Medical Research, 11, Article No. 41. [Google Scholar] [CrossRef] [PubMed]
[12] Gómez, G.I., Alvear, T.F., Roa, D.A., Farias-Pasten, A., Vergara, S.A., Mellado, L.A., et al. (2024) CX43 Hemichannels and PANX1 Channels Contribute to Ethanol-Induced Astrocyte Dysfunction and Damage. Biological Research, 57, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[13] Fierro-Arenas, A., Landskron, G., Camhi-Vainroj, I., Basterrechea, B., Parada-Venegas, D., Lobos-González, L., et al. (2024) Pannexin-1 Expression in Tumor Cells Correlates with Colon Cancer Progression and Survival. Life Sciences, 351, Article ID: 122851. [Google Scholar] [CrossRef] [PubMed]
[14] Santavanond, J.P., Chiu, Y., Tixeira, R., Liu, Z., Yap, J.K.Y., Chen, K.W., et al. (2024) The Small Molecule Raptinal Can Simultaneously Induce Apoptosis and Inhibit PANX1 Activity. Cell Death & Disease, 15, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
[15] Jorquera, G., Meneses-Valdés, R., Rosales-Soto, G., Valladares-Ide, D., Campos, C., Silva-Monasterio, M., et al. (2021) High Extracellular ATP Levels Released through Pannexin-1 Channels Mediate Inflammation and Insulin Resistance in Skeletal Muscle Fibres of Diet-Induced Obese Mice. Diabetologia, 64, 1389-1401. [Google Scholar] [CrossRef] [PubMed]
[16] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[17] Adamson, S.E., Meher, A.K., Chiu, Y., Sandilos, J.K., Oberholtzer, N.P., Walker, N.N., et al. (2015) Pannexin 1 Is Required for Full Activation of Insulin-Stimulated Glucose Uptake in Adipocytes. Molecular Metabolism, 4, 610-618. [Google Scholar] [CrossRef] [PubMed]
[18] Bartley, C., Brun, T., Oberhauser, L., Grimaldi, M., Molica, F., Kwak, B.R., et al. (2019) Chronic Fructose Renders Pancreatic β-Cells Hyper-Responsive to Glucose-Stimulated Insulin Secretion through Extracellular ATP Signaling. American Journal of Physiology-Endocrinology and Metabolism, 317, E25-E41. [Google Scholar] [CrossRef] [PubMed]
[19] Liong, S. and Lappas, M. (2015) Endoplasmic Reticulum Stress Is Increased in Adipose Tissue of Women with Gestational Diabetes. PLOS ONE, 10, e0122633. [Google Scholar] [CrossRef] [PubMed]
[20] Huang, G., Bao, J., Shao, X., Zhou, W., Wu, B., Ni, Z., et al. (2020) Inhibiting Pannexin-1 Alleviates Sepsis-Induced Acute Kidney Injury via Decreasing NLRP3 Inflammasome Activation and Cell Apoptosis. Life Sciences, 254, Article ID: 117791. [Google Scholar] [CrossRef] [PubMed]
[21] Huang, Y., Bai, Z. and Sui, S. (2024) Mir-224-5p Alleviates Preeclampsia-Like Mouse Symptoms by Targeting PANX1 to Inhibit Ferroptosis in Trophoblast Cells. Placenta, 158, 113-125. [Google Scholar] [CrossRef] [PubMed]
[22] El-Khalik, S.R.A., Ibrahim, R.R., Ghafar, M.T.A., Shatat, D. and El-Deeb, O.S. (2022) Novel Insights into the SLC7A11-Mediated Ferroptosis Signaling Pathways in Preeclampsia Patients: Identifying Pannexin 1 and Toll-Like Receptor 4 as Innovative Prospective Diagnostic Biomarkers. Journal of Assisted Reproduction and Genetics, 39, 1115-1124. [Google Scholar] [CrossRef] [PubMed]